Влезте в профила си за пълен достъп до възможностите на Eclipse.
Вход
Каталог "Библиографии"
| Списание
Impact of prior treatment on patients with relapsed multiple myeloma treated with carfilzomib and dexamethasone vs bortezomib and dexamethasone in the phase 3 ENDEAVOR study
Moreau, P., Goranova-Marinova, V., al., e. Impact of prior treatment on patients with relapsed multiple myeloma treated with carfilzomib and dexamethasone vs bortezomib and dexamethasone in the phase 3 ENDEAVOR study,
, .
Moreau, P., Goranova-Marinova, V., al., e. .
Impact of prior treatment on patients with relapsed multiple myeloma treated with carfilzomib and dexamethasone vs bortezomib and dexamethasone in the phase 3 ENDEAVOR study.
: , .
Moreau, P., Goranova-Marinova, V., al., e. ()
Impact of prior treatment on patients with relapsed multiple myeloma treated with carfilzomib and dexamethasone vs bortezomib and dexamethasone in the phase 3 ENDEAVOR study,
:
Moreau, P.,
Goranova-Marinova, V., &
al., e.
().
Impact of prior treatment on patients with relapsed multiple myeloma treated with carfilzomib and dexamethasone vs bortezomib and dexamethasone in the phase 3 ENDEAVOR study. Leukemia; Leukemia.